Immuno-Biological Laboratories Company Description

Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer’s disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems.

It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies.

In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases.

Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production.

The company was incorporated in 1982 and is headquartered in Fujioka, Japan.

Immuno-Biological Laboratories Co., Ltd.

Country	Japan
Founded	1982
Industry	Biotechnology
Sector	Healthcare
Employees	58
CEO	Tsutomu Seito

Contact Details

Address: Fujioka Laboratory Fujioka, 375-0005 Japan
Phone	81 2 7422 2889
Website	ibl-japan.co.jp

Stock Details

Ticker Symbol	4570
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3921300004
SIC Code	2834

Key Executives

Name	Position
Tsutomu Seito	Chief Executive Officer
Masato Nakagawa	Chief Operating Officer